Harrow, Inc. reported $276M of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $276M (to Q2 2026). Net income: −$37M, trailing twelve months to Q2 2026. Free cash flow: $5.0M, trailing twelve months to Q2 2026. Operating margin: −6.9%, trailing twelve months to Q2 2026.

HROWHarrow, Inc.

Healthcare

$29.36-34% 1Y

$29.36

$29.0352 weeks$54.80

HROW as reported

Harrow, Inc. reported $276M of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed.

$276M

Revenue, trailing twelve months · to Q2 2026 · +21% against the twelve months before

Net income: −$37M
Net income · +264% year on year · trailing twelve months to Q2 2026
Free cash flow: $5.0M
Free cash flow · +97% year on year · trailing twelve months to Q2 2026
Operating margin: −6.9%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HROW, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$276M	+21%	Q2 2026
Net income	−$37M	+264%	Q2 2026
EPS	−$0.99	+230%	Q2 2026
Gross margin	72%	n/a	Q2 2026
Operating margin	−6.9%	n/a	Q2 2026
Net margin	−20%	n/a	Q2 2026
ROE	−79%	n/a	Q2 2026
ROA	−3.8%	n/a	Q2 2026
ROIC	5.0%	n/a	Q2 2026
Free cash flow	$5.0M	+97%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.